154 related articles for article (PubMed ID: 1703606)
1. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
Sheldon RS; Rahmberg M; Duff HJ
J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
[TBL] [Abstract][Full Text] [Related]
2. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
Duff HJ; Rahmberg M; Sheldon RS
J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
[TBL] [Abstract][Full Text] [Related]
3. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
Duff HJ
J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
[TBL] [Abstract][Full Text] [Related]
4. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
Cha Y; Wales A; Wolf P; Shahrokni S; Sawhney N; Feld GK
J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antiarrhythmic activity of quinidine and quinine.
Klevans LR; Kelly RJ; Kovacs JL
Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
10. Intraindividual comparison of intravenous ajmaline and quinidine in patients with sustained ventricular tachycardia: effects on normal myocardium and on arrhythmia characteristics.
Lengfelder W; Senges J; Rizos I; Jauernig R; Brachmann J; von Ohlshausen K; Kübler W
Eur Heart J; 1985 Apr; 6(4):312-22. PubMed ID: 4029187
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
12. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL
Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732
[TBL] [Abstract][Full Text] [Related]
13. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
Dorian P; Newman D; Berman N; Hardy J; Mitchell J
J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Toivonen L; Kadish A; Morady F
Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
[TBL] [Abstract][Full Text] [Related]
15. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
Duff HJ; Gault NJ
J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
[TBL] [Abstract][Full Text] [Related]
16. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
Gold RL; Haffajee CI; Alpert JS
Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
[TBL] [Abstract][Full Text] [Related]
18. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
19. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
[TBL] [Abstract][Full Text] [Related]
20. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.
Roden DM; Hoffman BF
Circ Res; 1985 Jun; 56(6):857-67. PubMed ID: 4006095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
